Human study of iPS cells advances toward approval in Japan

A panel of Japan's Health Ministry has approved a clinical study involving induced pluripotent stem cells. The study is a type of pretrial clinical research that will focus on the use of iPS cells in treating eye disease. The decision could pave the way for final approval by the health minister.

View Full Article in:

Japan Times, The · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ